Список литературы

2687-0940

Challenges in modern medicine

2687-0940

10.52575/2687-0940-2023-46-1-38-48

142

CARDIOLOGY

<strong>The Role of Obesity in the Likelihood of Cardiovascular Event</strong>

Basyrova

Irina R.

Basyrova

Irina R.

Dushina

Alena G.

Dushina

Alena G.

al.dushina@yandex.ru

Lopina

Ekaterina A.

Lopina

Ekaterina A.

Libis

Roman A.

Libis

Roman A.

2023

46100

The urgency of the problem of obesity becomes more obvious every year. Statistical data testify to the revitalization of this problem. The trail of comorbid pathology (coronary heart disease, arterial hypertension, type 2 diabetes mellitus) prompts the search for methods to prevent the development of obesity. The body mass index is insufficient to predict obesity and its complications. Taking into account age and gender characteristics, the presence of risk factors, the assessment of the visceral obesity index and the metabolic phenotype of obesity should become the foundation for a personalized approach to preventing the risk of developing cardiovascular events.

central obesity indexlipid accumulation product indexvisceral obesity index

Список литературы

Aleksandrova Yu.D., Kolosnicyna M.G. 2018. Problema izby`tochnogo vesa naseleniya Rossii: statisticheskij analiz [Overweight population in Russia: statistical analysis.]. Voprosy` statistiki. 25 (10): 61–77.

Brodovskaya T.O., Kovin E.A., Bazhenova O.V., Grishina I.F., Peretolchina T.F. 2019. Prediktory` visceral`nogo ozhireniya u pacientov s sindromom obstruktivnogo apnoe` sna i normal`noj massoj tela [Predictors of visceral obesity in normal weight obstructive sleep apnea patients]. Ozhirenie i metabolizm. 16 (2): 29–35. doi: 10.14341/omet9737

Volkova N.I., Ganenko L.A., Porksheyan M.I. 2017. Metabolicheski zdorovoe ozhirenie, chto my` o nem znaem [Metabolic healthy obesity, what do we know about it]? Medicinskij vestnik Yuga Rossii. 8 (3): 6–16. doi: 10.21886/2219-8075-2017-8-3-6-16

Dedov I.I., Mel`nichenko G.A., Shestakova M.V., Troshina E.A., Mazurina N.V., Shestakova E.A., Yashkov Yu.I., Nejmark A.E., Biryukova E.V., Bondarenko I.Z., Bordan N.S., Dzgoeva F.X., Ershova E.V., Komshilova K.A., Mkrtumyan A.M., Petunina N.A., Romanczova T.I., Starostina E.G., Strongin L.G., Suplotova L.A., Fadeev V.V. 2018. Nacional`ny`e klinicheskie rekomendacii po lecheniyu morbidnogo ozhireniya u vzrosly`x. 3-j peresmotr [Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision] (Lechenie morbidnogo ozhireniya u vzrosly`x). Ozhirenie i metabolizm. 15 (1): 53–70. doi: 10.14341/omet2018153-70

Ozhirenie v Rossii: statisticheskie danny`e [Obesity in Russia: statistics]. 2013. URL: http:// health.passion.ru/novosti-zdorovya/lishniives/ozhirenie-v-rossii-statisticheskie-dannye.htm

Ostroumova O.D., Kochetkov A.I., Kopchenov I.I., Fomina V.M. 2017. Arterial`naya gipertoniya v sochetanii s izby`tochnoj massoj tela i ozhireniem. Vozmozhnosti kombinacii amlodipina i lizinoprila. Chast` 1. Osobennosti sutochnogo profilya arterial`nogo davleniya i porazheniya serdcza kak organa-misheni u bol`ny`x s arterial`noj gipertoniej v sochetanii s izby`tochnoj massoj tela i ozhireniem [Arterial hypertension in the presence of overweight and obesity. The capabilities of amlodipine and lisinopril combination. Part 1. Features of the daily profile of blood pressure and heart damage as a target organ in patients with arterial hypertension in combination with overweight and obesity]. Racional`naya farmakoterapiya v kardiologii. 13 (5): 693–8. doi: 10.20996/1819-6446-2017-13-5-693-698

Svarovskaya A.V., Garganeeva A.A. 2021. Antropometricheskie indeksy` ozhireniya i kardiometabolicheskij risk: est` li svyaz` [Anthropometric indices obesity and cardiometabolic risk: is there a link]? 2021. Kardiovaskulyarnaya terapiya i profilaktika. 20 (4): 114–21. doi: 10.15829/1728-8800-2021-2746

Horlampenko A.A., Karetnikova V.N., Kochergina A.M., Ignatova Yu.S., Belik E.V., Gruzdeva O.V., Brel` N.K., Kokov A.N., Barbarash O.L. 2020. Indeks visceral`nogo ozhireniya u pacientov s ishemicheskoj bolezn`yu serdcza, ozhireniem i saxarny`m diabetom 2 tipa [Visceral adiposity index in patients with coronary artery disease, obesity and type 2 diabetes]. Kardiovaskulyarnaya terapiya i profilaktika. 19 (3): 173–80. doi: 10.15829/1728-8800-2020-2311

Chumakova G.A., Kuzneczova T.Yu., Druzhilov M.A, Veselovskaya N.G. 2018. Visceral`noe ozhirenie kak global`ny`j faktor serdechno-sosudistogo riska [Visceral adiposity as a global factor of cardiovascular risk]. Rossijskij kardiologicheskij zhurnal. 23 (5): 7–14. doi: 10.15829/1560-4071-2018-5-7-14

Shal`nova S.A., Deev A.D., Muromceva G.A., Balanova Yu.A., Imaeva A.E`., Kapustina A.V., Evstifeeva S.E., Shepel` R.N., Rotar` O.P., Nedogoda S.V., Shabunova A.A., Cherny`x T.M., Romanchuk S.V., Indukaeva E.V., Grinshtejn Yu.I., Libis R.A., Duplyakov D.V., Trubacheva I.A., Efanov A.Yu., Tolparov G.V., Kulakova N.V., Shlyaxto E.V., Bojczov S.A., Drapkina O.M. ot imeni uchastnikov issledovaniya E`SSE`-RF. 2018. Antropometricheskie indeksy` i ix svyaz` s ishemicheskoj bolezn`yu serdcza [Relation of anthropometric indexes and coronary heart disease]. Kardiovaskulyarnaya terapiya i profilaktika. 17 (3): 11–6. doi: 10.15829/1728-8800-2018-3-11-16

Bastien M., Poirier P., Lemieux I., Després J.P. 2014. Overview of epidemiology and contribution of obesity to cardiovascular disease. Progress in Cardiovascular Diseases. 56 (4): 369–81. doi: 10.1016/j.pcad.2013.10.016

Carbone S., Canada J.M., Billingsley H.E., Siddiqui M.S., Elagizi A., Lavie C.J. 2019. Obesity paradox in cardiovascular disease: where do we stand? Vascular Health and Risk Management. 15: 89–100. doi: 10.2147/vhrm.s168946

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. 2021. European Heart Journal. 42 (36): 3599–3726. doi: 10.1093/eurheartj/ehab368

Gilani N., Kazemnejad I., Zayeri F., Hadaegh F., Azizi F., Khalili D. 2017. Anthropometric indices as predictors of coronary heart disease risk: joint modeling of longitudinal measurements and time to event. Iranian Journal of Public Health. 46 (11): 1546–54.

Hosseinpanah F., Barzin M., Mirbolouk M., Abtahi H., Cheraghi L., Azizi F. 2016. Lipid accumulation product and incident cardiovascular events in a normal weight population: Tehran Lipid and Glucose Study. European Journal of Preventive Cardiology. 23 (2): 187–93. doi: 10.1177/2047487314558771

Kouli G.-M., Panagiotakos D.B., Kyrou I., Georgousopoulou E.N., Chrysohoou C., Tsigos C., Tousoulis D., Pitsavos C. 2017. Visceral adiposity index and 10-year Cardiovascular Disease incidence: the ATTICA Study. Nutrition, Metabolism and Cardiovascular Diseases. 27 (10): 881–9. doi: 10.1016/j.numecd.2017.06.015

Kramer C.K., Zinman B., Retnakaran R. 2013. Are metabolically healthy overweight and obesity benign conditions? A systematic review and metaanalysis. Annals of Internal Medicine. 159 (11): 758–69. doi: 10.7326/0003-4819-159-11-201312030-00008

Neeland I.J., Poirier P., Després J.P. 2018. Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management. Circulation. 137 (13): 1391–1406. doi: 10.1161/CIRCULATIONAHA.117.029617

Ray L., Ravichandran K., Nanda S.K. 2018. Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in Indian population. Metabolic Syndrome and Related Disorders. 16 (5): 240–5. doi: 10.1089/met.2017.0119

The GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. 2017. The New England Journal of Medicine. 377 (1): 13–27. doi: 10.1056/nejmoa1614362